The Zacks Analyst Blog Highlights Taiwan, Johnson & Johnson, Palantir, Title and Altigen

Zacks
Apri Zacks
The Zacks Analyst Blog Highlights Taiwan, Johnson & Johnson, Palantir, Title and Altigen

For Immediate Release

Chicago, IL – November 17, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Taiwan Semiconductor Manufacturing Co. Ltd. TSM, Johnson & Johnson JNJ, Palantir Technologies Inc. PLTR and Title Company ITIC and Altigen Communications, Inc. ATGN.

Here are highlights from Tuesday’s Analyst Blog:

Top Analyst Reports for Taiwan Semi, Johnson & Johnson and Palantir

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Taiwan Semiconductor Manufacturing Co. Ltd., Johnson & Johnson and Palantir Technologies Inc., as well as two micro-cap stocks Investors Title Company and Altigen Communications, Inc.The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Today's Featured Research Reports

Taiwan Semiconductor’s shares were in line with the Zacks Semiconductor - Circuit Foundry industry over the year-to-date period (+32% vs. +32%). The company benefits from rising demand for AI computing and a process roadmap that brings customers to successive technology generations. Its design ecosystem and advanced packaging services deepen customer relationships, while manufacturing scale and cash generation support continued investment. 

Overseas capacity adds geographic choice for customers but carries lasting cost disadvantages. Heavy capital commitments and recurring new-process ramp costs can limit how much revenue growth converts into shareholder cash returns. 

Customer concentration, supply bottlenecks and uneven consumer demand also constrain the breadth of growth. Currency exposure, export licensing, and a production base concentrated in Taiwan leave earnings sensitive to factors beyond chip adoption, even as productivity efforts partially offset them.

(You can read the full research report on Taiwan Semiconductor here >>>)

Shares of Johnson & Johnson have outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+40.3% vs. +29.1%). The company’s Innovative Medicines unit is its primary growth engine despite Stelara LOE, driven by key products like Darzalex, Tremfya and Erleada and new drugs, Spravato, Carvykti and Tecvayli. J&J has also rapidly advanced its pipeline in the past year that will help drive growth through the back half of the decade. 

The company has “line of sight” to double-digit top-line growth by the end of the decade. However, J&J’s MedTech growth remains constrained by weaker Abiomed demand, China’s volume-based procurement and electrophysiology competition. 

J&J also faces pressure from Stelara’s LOE and rising generic/biosimilar competition across several drugs. The talc litigation also remains a financial overhang, with the proposed settlement still conditional.

(You can read the full research report on Johnson & Johnson here >>>)

Palantir’s shares have underperformed the Zacks Internet - Software industry over the year-to-date period (-5.5% vs. -2%). The company is facing intense competition from larger rivals, rising technical expenses and fixed cloud commitments could pressure margins and constrain cost flexibility. Concentrated receivables pose cash flow risks, while the absence of dividends limits its appeal to income-focused investors. 

These risks temper growth prospects, supporting a Neutral recommendation on PLTR. Nevertheless, PLTR’s share pieces reflecting optimism surrounding its AI-driven growth prospects. 

Rising adoption of its AI platforms across government and commercial markets, expanding customer relationships and strong cash generation support sustained growth. Its land-and-expand strategy and ample liquidity provide flexibility to fund innovation, product development and technical hiring. 

(You can read the full research report on Palantir here >>>)

Shares of Investors Title have gained +4.5% over the year-to-date period against the Zacks Insurance - Property and Casualty industry’s gain of +16.3%. This microcap company with a market capitalization of $480.47 million sees its premium growth supported by higher real estate transaction volumes, geographic expansion and favorable net title insurance rate changes. Third-quarter 2026 net premiums written rose 20.9%, while its sizable investment portfolio and sound liquidity provide resilience. 

The board also declared a $19.27-per-share special dividend alongside its regular quarterly payout. However, claims provisions and agent commissions rose sharply, contributing to a decline in third-quarter earnings and margins. 

Weakness in like-kind exchange activity limits diversification, and the title business remains sensitive to housing conditions and concentrated regional markets. These offsetting factors temper the outlook despite continued premium momentum, substantial capital resources and long-term expansion opportunities.

(You can read the full research report on Investors Title here >>>)

Altigen Communications’ shares have gained +1% over the year-to-date period against the Zacks Communication - Components industry’s gain of +38.1%. This microcap company with a market capitalization of $11.13 million, has seen its cloud transition gaining momentum as new cloud revenues have begun exceeding legacy churn, supported by its largest-ever cloud customer, larger enterprise wins and an expanding AI portfolio. 

CoreInteract, CoreEngage and CoreInsights broaden its addressable market and create cross-selling opportunities, while the Fiserv relationship offers a scalable channel into financial services. Its installed MAXCloud and MaxCS base also provides a lower-friction path for cloud migrations and AI adoption. 

However, the company's fiscal third-quarter revenues fell 14.2%, margins compressed, and customer concentration remained high at 74% for the top five customers and resellers. Rising development spending and impairment risk add uncertainty. At 0.61X EV/sales, valuation remains below industry levels and historical medians. 

(You can read the full research report on Altigen Communications here >>>)

 

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Johnson & Johnson (JNJ): Free Stock Analysis Report
 
Taiwan Semiconductor Manufacturing Company Ltd. (TSM): Free Stock Analysis Report
 
Investors Title Company (ITIC): Free Stock Analysis Report
 
AltiGen Communications Inc. (ATGN): Free Stock Analysis Report
 
Palantir Technologies Inc. (PLTR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research